In France, the legal routes used to administer midazolam to a patient are intravenously and
intramuscularly. For anaesthetists, these routes are not well adapted to paediatric use; they …

In absence of dedicated children formulation, intravenous formulations of midazolam, which
exhibit strong bitterness, are occasionally used for oral or sublingual administration. In order …

We compared two available oral formulations of midazolam with respect to sedation score
and plasma midazolam levels in pediatric surgical patients 2–10 yr old. The commercially …

In this study, the authors evaluate the pharmacodynamics, safety, and acceptability of a new
cherry‐flavored oral syrup formulation of midazolam. This randomized, double‐blind …

Pharmacokinetic, pharmacodynamic and pharmacogenomic studies of midazolam are
currently being performed in critically ill children to find suitable dose regimens. Sensitive …

Objective: To determine midazolam pharmacokinetics in healthy Mexican volunteers and to
compare them with the pharmacokinetics reported for other populations. Patients and …

Midazolam is a benzodiazepine with short elimination half-life, used as induction or
continuous agent for general anesthesia. At present, only injectable solution is available …

Objective We investigated the pharmacologic properties of midazolam with special regard to
age using the electroencephalogram (EEG) as a measure of the hypnotic‐sedative effect …

Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …

Interventions The pharmacokinetics of midazolam and metabolites were determined during
and after a continuous infusion of midazolam (0.05–0.4 mg/kg/hr) for 3.8 hrs to 25 days …